BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $1.35 and last traded at $1.32, with a volume of 37345 shares trading hands. The stock had previously closed at $1.34.
BioRestorative Therapies Stock Performance
The company has a 50 day moving average of $1.37 and a 200 day moving average of $1.69. The stock has a market capitalization of $2.15 billion, a price-to-earnings ratio of -1.22 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- Market Cap Calculator: How to Calculate Market Cap
- United Airlines Soars on Earnings Beat
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- J.B. Hunt Hits the Skids: Lower Prices to Come
- 3 Stocks to Consider Buying in October
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
